$DTSS

Datasea Intelligent Technology (DTSS) reported that the aggregate value of AI agent services provided to five customers reached $4.0 million as of October 8, up from $1.10 million in September 2026. The company operates in acoustic technology and AI solutions, with services billed based on actual platform usage. CEO Zhixin Liu emphasized the importance of customer usage over agreement signings. DTSS plans to expand its AI applications across various industries and markets.

Datasea reported fiscal 2026 results with a 70.1% increase in gross profit and a gross margin of 10.2%, despite a revenue decline. The company did not provide a full breakdown of financials.

U.S. stocks rose midday, with S&P 500 up 1%. Pending home sales increased 0.3% in August. Aethlon Medical (AEMD) surged 390% on merger news. Datasea (DTSS) rose 81% on AI service agreements. Fluence Energy (FLNC) fell 14% after price target cuts. Oil dropped 1.4%, gold up 0.4%. European and Asian markets mixed.

Datasea Intelligent Technology (DTSS) shares rose 45.38% to $0.85 in overnight trading, following a 7.63% drop the previous day. The stock saw high trading volume, 180 times its average, with no clear catalyst identified. The company operates in network security and 5G data messaging. DTSS has a market cap of $6.176 million and a 52-week range of $0.53 to $2.50.

Datasea Intelligent Technology (DTSS) is expanding its strategic cooperation with Nanjing Linghang Intelligent Aviation to develop AI-powered elderly care robots, targeting China's trillion-RMB silver economy. The partnership combines Datasea's AI and digital platform capabilities with Linghang's robotics technologies. China's aging population, with 323.38 million people aged 60+, presents a significant market opportunity for intelligent elderly care solutions. Datasea aims to establish a broade

Datasea Intelligent Technology Ltd. (NASDAQ: DTSS) said its China VIE, Shuhai Jingwei, completed FDA establishment registration and device listing for the NeuroVibe acoustic biofeedback system (NV-02, NV-03). The devices were listed as Class II 510(k)-exempt biofeedback medical devices under FDA product code HCC. Datasea said this supports U.S. commercialization planning; listing is not FDA approval.

Liu Fu sold (to issuer) 2,000,000 shares of Datasea Intelligent Technology Ltd. (DTSS) at $1.07 ($2.14M total) on 2026-04-16.

Liu Zhixin (CEO) sold (to issuer) 2,000,000 shares of Datasea Intelligent Technology Ltd. (DTSS) at $1.07 ($2.14M total) on 2026-04-16.

Datasea Inc. announced its redomiciliation to the British Virgin Islands through a merger with its wholly-owned subsidiary, Datasea Intelligent Technology Ltd., effective April 15, 2026. Existing shareholders will receive one-for-one Class A ordinary shares, while key insiders Zhixin Liu and Fu Liu will hold Class B shares, and the company's Nasdaq trading under the DTSS symbol will continue with a new CUSIP. TipRanks’ AI Analyst, Spark, rates DTSS as Neutral due to weak financial performance and a bearish technical trend, despite some improvements in cash flow.

Datasea Inc. announced its plan to redomicile to the British Virgin Islands (BVI) through a merger with its wholly-owned BVI-incorporated subsidiary, Datasea Intelligent Technology Ltd. (DIT). Upon the merger's effectiveness, Datasea will cease to exist, and DIT Class A ordinary shares will begin trading on the Nasdaq Capital Market under Datasea's previous symbol, "DTSS."